Semintra 4 mg/mL vs 10 mg/mL: Why the Concentration and Market Change the Label Meaning

If you are comparing Semintra bottles or online listings, do not identify the product by brand name alone. The US label describes Semintra as a 10 mg/mL telmisartan oral solution for controlling systemic hypertension in cats, while the European product information includes a 4 mg/mL formulation with different labeled uses and package details. These labels should not be treated as interchangeable merely because they contain the same active ingredient.

The key check is whether the bottle and carton match the market-specific label your veterinarian intended.

The two labels at a glance

The US information comes from the current DailyMed label and the FDA Freedom of Information Summary for NADA 141-501. The European information comes from the European Commission product information for the 4 mg/mL product.

This comparison describes what the cited labels say. It does not determine which product or indication is appropriate for an individual cat.

Why 4 mg/mL and 10 mg/mL are not the same label

Concentration states how much telmisartan is contained in each milliliter of solution. A 4 mg/mL solution and a 10 mg/mL solution therefore contain different amounts of active ingredient in the same measured volume.

That difference matters because the volume marked on a syringe is not, by itself, the medication amount. A prescription written for one concentration cannot automatically be measured from a bottle containing the other concentration. Converting between them requires the prescribing veterinarian or dispensing pharmacist to verify the intended telmisartan amount, the formulation, and the applicable instructions.

The FDA approval record adds an important nuance: the US development program included studies using a 4 mg/mL solution, while the marketed US formulation was 10 mg/mL. The FDA summary also describes a pharmacokinetic comparison between the two formulations. That study information does not make every 4 mg/mL bottle equivalent to the US-approved product, and it does not transfer a US indication or dosing instruction to a product labeled for another market.

The approved product, concentration, indication, route, and jurisdiction must remain connected to the exact label.

What the market changes

A brand name can appear in more than one national regulatory system. Each system may authorize a particular formulation for particular uses.

For the US product identified in the cited label:

• The concentration is 10 mg/mL.

• The target species is cats.

• The labeled indication is control of systemic hypertension.

• The application number is NADA 141-501.

• The package described by the label contains 35 mL in a 45 mL plastic bottle with a dosing syringe.

• The product is restricted to use by or on the order of a licensed veterinarian.

For the European 4 mg/mL product information cited here:

• The concentration is 4 mg/mL.

• The target species is cats.

• The stated indication is reduction of proteinuria associated with chronic kidney disease.

• The cited authorization number is EU/2/12/146/001.

• The package contains 30 mL in a 45 mL bottle with a measuring syringe.

• The product is subject to veterinary prescription.

These are not merely different ways of describing the same package. They are label fields tied to different regulatory documents and markets. A European label does not establish US approval, and a US approval does not establish the indication or dispensing rules for a product supplied under a European authorization.

How to match your package

Before interpreting directions, compare the bottle and carton with the following six fields.

1. Market or jurisdiction

Look for the country or regulatory information printed on the carton, package leaflet, or dispensing label. A product obtained outside the United States may carry a foreign authorization and instructions that do not match the US label.

A shipping destination or an English-language website does not, by itself, establish that the product is a US-labeled product.

2. Concentration

Find the statement showing the amount of telmisartan per milliliter:

• 10 mg/mL corresponds to the US label cited above.

• 4 mg/mL corresponds to the European label cited above.

Do not rely only on the product name, bottle color, syringe appearance, or an online listing. The concentration printed on the bottle or carton is the controlling identity field for this check.

3. Package volume and container

Compare the stated fill volume and container description:

• The cited US label identifies a 35 mL fill volume in a 45 mL plastic bottle.

• The cited European 4 mg/mL information identifies 30 mL in a 45 mL bottle.

Pack size alone does not prove the market or indication, but a mismatch can help identify a question for the dispensing pharmacy or veterinarian.

4. Indication

Check what condition the label says the product is intended to address:

• The US label states control of systemic hypertension in cats.

• The cited European 4 mg/mL label states reduction of proteinuria associated with CKD in cats.

Hypertension and CKD-associated proteinuria are related clinical issues but are not the same label indication. A cat may have one, both, or neither. The diagnosis and treatment objective must come from the veterinarian’s assessment rather than from the product name.

For broader disease context, see HERO’s educational resource on controlling pet blood pressure over the long term or its discussion of vasodilators and chronic kidney disease in pets. Those pages provide disease education; they do not replace the exact label or a prescription-specific review.

5. Authorization or application number

Record the identifier exactly as printed:

• US: NADA 141-501.

• European 4 mg/mL product information cited here: EU/2/12/146/001.

An authorization number is more useful than a brand name when clarifying a label conflict. It helps the professional reviewing the product locate the corresponding regulatory document.

6. Dispensing and instruction details

Photograph or record:

• The full front and back of the carton.

• The bottle label, including concentration and fill volume.

• The authorization or application number.

• The lot number and expiration date.

• The supplied syringe and its markings.

• The pharmacy dispensing label, if present.

• The country where the product was dispensed or purchased.

Take the images and the prescription to the veterinarian or dispensing pharmacy. Ask them to confirm that the bottle concentration, syringe instructions, prescribed indication, and market-specific label all refer to the same product.

What not to infer from the comparison

A concentration difference does not by itself establish that one product is stronger, safer, or more effective. It primarily tells you that the amount of active ingredient per milliliter differs.

Likewise, the presence of the same active ingredient does not prove that:

• The products have the same approved indication in your country.

• The same volume markings can be used.

• The same directions apply.

• A foreign product is authorized for sale or dispensing in the United States.

• A product from an online source has verified provenance.

• One bottle can be substituted for another without professional confirmation.

Do not change the volume, frequency, or product based on a conversion found online. If the bottle concentration conflicts with the prescription, pause and contact the prescribing veterinarian or dispensing pharmacy. If your cat may have received more than prescribed, or develops a suspected adverse reaction, contact the veterinarian promptly.

A note about online product pages

A commercial page may use a brand name, ingredient description, image, or concentration that does not clearly identify the regulatory market. The page should not be treated as proof of FDA approval, lawful US dispensing, or equivalence to the US-labeled product.

The US reference for the product discussed here is the FDA-approved NADA 141-501 label: 10 mg/mL telmisartan oral solution for control of systemic hypertension in cats. If a commercial page describes a 4 mg/mL product as the US FDA-approved product, that statement requires clarification against the current US label before the page is used to identify the medication.

A product page can also change after publication. When the bottle, carton, pharmacy label, and website do not agree, use the exact package and regulatory details as the starting point for professional verification rather than assuming that the most convenient description is correct.

The mismatch note to bring to a professional

You can write the following information on a note or send it with the package photographs:

My cat was prescribed or is using Semintra. The bottle says: _ mg/mL.
The bottle contains: _ mL.
The carton or label identifies this market or authorization as: _.
The prescription states: _.
Please confirm that the concentration, syringe markings, intended indication, and directions match the exact product dispensed.

If the concentration is 4 mg/mL but the prescription or US label reference expects 10 mg/mL, identify that specific mismatch. Do not attempt to correct it by changing the measured volume yourself. If the indication, package size, authorization number, or dispensing label also differs, include those fields in the same clarification request.